Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 4/2017

01-12-2017 | Original Article

The Impact of Transfusion and Chelation on Oxidative Stress in Immigrant Syrian Children with β-Thalassemia

Authors: Meriç Kaymak Cihan, Burcu Belen, Fatih Bolat, Özlem Gümüştekin Bülbül, Elif Ünver Korgalı, Ülker Koçak

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 4/2017

Login to get access

Abstract

Iron overload in β-thalassemia major and intermedia patients leads to oxidative stress and causes to formation of lipid hydroperoxides. Thiobarbituric acid reactive substances (TBARS) are a well established method for screening and monitoring of lipid peroxidation. We aimed to investigate serum TBARS and its relationship with biochemical and hematologic parameters of Turkish and immigrant Syrian β-thalassemia children reflecting the effects of this socioeconomic condition on follow up of these patients. Lipid peroxidation products (TBARS) of Turkish (TR) (n = 62, from the cities of Gaziantep and Sivas, Turkey) and Syrian (SYR) (n = 34, from Gaziantep, Turkey) β-thalassemia patients aged 2–17 years and 58 healthy subjects aged 2–16 years were studied. Liver and renal function tests, serum ferritin levels, white blood cell, absolute neutrophil and platelet counts, hemoglobin (Hb) levels of the patients were analyzed. Serum TBARS concentrations were found to be elevated in β-thalassemia patients compared to healthy subjects (mean: 12.47 ± 8.53 vs. 9.78 ± 7.09, p = 0.045). In SYR patients mean pretransfusional Hb level (7.26.2.04 vs. 8.49 ± 1.01, p = 0.002) was lower and ferritin levels (5983.56 ± 5065.56 vs. 3234.60 ± 2237.82, p = 0.001), liver enzymes (ALT: 77.82 ± 76.48 vs. 42.13 ± 51.50, p = 0.005) were higher when compared to TR group. Positive correlation between TBARS and ferritin levels (p = 0.029, r = 0.231) and liver enzymes (for ALT p < 0.001, r = 0.373) was observed. β-thalassemia patients are under more oxidative stress than healthy subjects. Liver is one of the major organs which are mainly affected by oxidative stress. War and migration might have caused inappropriate transfusion conditions and insufficient chelation therapy in the SYR group.
Literature
1.
go back to reference Lanskowsky P (2011) Manual of pediatric hematology and oncology, 5th edn. Elsevier, San Diego Lanskowsky P (2011) Manual of pediatric hematology and oncology, 5th edn. Elsevier, San Diego
2.
3.
go back to reference Ferro E, Visalli G, Civa R et al (2012) Oxidative damage and genotoxicity biomarkers in transfused and untransfused thalassemic subjects. Free Radic Biol Med 53:1829–1837CrossRefPubMed Ferro E, Visalli G, Civa R et al (2012) Oxidative damage and genotoxicity biomarkers in transfused and untransfused thalassemic subjects. Free Radic Biol Med 53:1829–1837CrossRefPubMed
4.
go back to reference Orkin SH, Nathan DG, Gisburg D, Look AT, Fisher DE, Lux SE (2009) Nathan and Oski’s hematology of infancy and childhood, 7th edn. Saunders Elsevier, Philadelphia Orkin SH, Nathan DG, Gisburg D, Look AT, Fisher DE, Lux SE (2009) Nathan and Oski’s hematology of infancy and childhood, 7th edn. Saunders Elsevier, Philadelphia
5.
go back to reference Gutteridge JMC (1986) Iron promoters of fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS Lett 201:291–295CrossRefPubMed Gutteridge JMC (1986) Iron promoters of fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS Lett 201:291–295CrossRefPubMed
6.
go back to reference Yagi K (1998) Simple assay for the level of total lipid peroxides in serum or plasma. Methods Mol Biol 108:101–106PubMed Yagi K (1998) Simple assay for the level of total lipid peroxides in serum or plasma. Methods Mol Biol 108:101–106PubMed
7.
go back to reference Armstrong D, Browne R (1994) The analysis of free radicals, lipid peroxides, antioxidant enzymes and compounds to oxidative stress as applied to the clinical chemistry laboratory. Free Radic Diagn Med 366:43–58CrossRef Armstrong D, Browne R (1994) The analysis of free radicals, lipid peroxides, antioxidant enzymes and compounds to oxidative stress as applied to the clinical chemistry laboratory. Free Radic Diagn Med 366:43–58CrossRef
8.
go back to reference Cheng ML, Ho HY, Tseng HC et al (2005) Antioxidant deficit and enhanced susceptibility to oxidative damage in individuals with different forms of α-thalassaemia. Br J Heamatol 128:119–127CrossRef Cheng ML, Ho HY, Tseng HC et al (2005) Antioxidant deficit and enhanced susceptibility to oxidative damage in individuals with different forms of α-thalassaemia. Br J Heamatol 128:119–127CrossRef
9.
go back to reference Pavlova LE, Savov VM, Petkov HG et al (2007) Oxidative stress in patients with β-thalassemia major. Prilozi 28:145–154PubMed Pavlova LE, Savov VM, Petkov HG et al (2007) Oxidative stress in patients with β-thalassemia major. Prilozi 28:145–154PubMed
10.
go back to reference Meral A, Tuncel P, Sürmen-Gür E et al (2000) Lipid peroxidation and antioxidant status in β-thalassemia. Pediatr Hematol Oncol 17:687–693CrossRefPubMed Meral A, Tuncel P, Sürmen-Gür E et al (2000) Lipid peroxidation and antioxidant status in β-thalassemia. Pediatr Hematol Oncol 17:687–693CrossRefPubMed
11.
go back to reference Chakraborty I, Mitra S, Gachhui R et al (2010) Non-haem iron-mediated oxidative stress in hemoglobin E beta-thalassaemia. Ann Acad Med Singap 39:13–16PubMed Chakraborty I, Mitra S, Gachhui R et al (2010) Non-haem iron-mediated oxidative stress in hemoglobin E beta-thalassaemia. Ann Acad Med Singap 39:13–16PubMed
12.
go back to reference Cunningham MJ, Sankaran VG, Nathan DG, Orkin SH (2009) The thalassemias. In: Orkin SH, Nathan DG, Gisburg D, Look AT, Fisher DE, Lux SE (eds) Nathan and Oski’s hematology of infancy and childhood, 7th edn. Saunders Elsevier, Philadelphia, pp 1015–1106 Cunningham MJ, Sankaran VG, Nathan DG, Orkin SH (2009) The thalassemias. In: Orkin SH, Nathan DG, Gisburg D, Look AT, Fisher DE, Lux SE (eds) Nathan and Oski’s hematology of infancy and childhood, 7th edn. Saunders Elsevier, Philadelphia, pp 1015–1106
13.
go back to reference Suthipark K, Ong-ajyooth S, Shumnumsirivath D et al (1987) Oxidative stress and antioxidants in beta-thalassemia/hemoglobin E. Birth Defects Orig Artic Ser 23:199–205PubMed Suthipark K, Ong-ajyooth S, Shumnumsirivath D et al (1987) Oxidative stress and antioxidants in beta-thalassemia/hemoglobin E. Birth Defects Orig Artic Ser 23:199–205PubMed
14.
go back to reference Kassab-Chekir A, Laradi S, Ferchichi S et al (2003) Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia. Clin Chim Acta 338:79–86CrossRefPubMed Kassab-Chekir A, Laradi S, Ferchichi S et al (2003) Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia. Clin Chim Acta 338:79–86CrossRefPubMed
15.
go back to reference Abdalla MY, Fawzi M, Al-Maloul SR et al (2011) Increased oxidative stress and iron overload in Jordanian β-thalassemic children. Hemoglobin 35:67–79CrossRefPubMed Abdalla MY, Fawzi M, Al-Maloul SR et al (2011) Increased oxidative stress and iron overload in Jordanian β-thalassemic children. Hemoglobin 35:67–79CrossRefPubMed
16.
go back to reference Britton RS, Leicester KL, Bacon BR (2002) Iron toxicity and chelation therapy. Int J Hematol 76:219–228CrossRefPubMed Britton RS, Leicester KL, Bacon BR (2002) Iron toxicity and chelation therapy. Int J Hematol 76:219–228CrossRefPubMed
17.
go back to reference Dasgupta S, Dasgupta A, Mukhopadhayay T et al (2013) Serum uric acid: an early indicator of oxidative stress in beta thalassemia population. Mymensingh Med J 22:567–573PubMed Dasgupta S, Dasgupta A, Mukhopadhayay T et al (2013) Serum uric acid: an early indicator of oxidative stress in beta thalassemia population. Mymensingh Med J 22:567–573PubMed
Metadata
Title
The Impact of Transfusion and Chelation on Oxidative Stress in Immigrant Syrian Children with β-Thalassemia
Authors
Meriç Kaymak Cihan
Burcu Belen
Fatih Bolat
Özlem Gümüştekin Bülbül
Elif Ünver Korgalı
Ülker Koçak
Publication date
01-12-2017
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 4/2017
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-017-0791-2

Other articles of this Issue 4/2017

Indian Journal of Hematology and Blood Transfusion 4/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine